Top No­var­tis man­u­fac­tur­ing ex­ec jumps ship, takes charge of in­dus­tri­al­iz­ing Mod­er­na’s mR­NA tech

A lit­tle over a year ago No­var­tis’ CEO Joe Jimenez put Juan An­dres in charge of a move to slice a bil­lion dol­lars out of the glob­al man­u­fac­tur­ing bud­get through a cen­tral­ized ser­vices project. It was a clas­sic No­var­tis move, win­kling out costs in its nev­er-end­ing stream­lin­ing ef­fort that had al­ready seen it re­vamp man­u­fac­tur­ing, with 25 fa­cil­i­ties re­struc­tured or di­vest­ed over a 6-year pe­ri­od.

Now An­dres is tak­ing his Big Man­u­fac­tur­ing skills gained in Big Phar­ma — in­clud­ing the pi­o­neer­ing work done on CAR-T man­u­fac­tur­ing — and putting it to work for Mod­er­na as the biotech preps its own cen­tral man­u­fac­tur­ing site for its mR­NA plat­form. Of­fi­cial­ly, he’s hand­ing in his ti­tle as glob­al head tech­ni­cal op­er­a­tions (man­u­fac­tur­ing and sup­ply) at No­var­tis for se­nior vice pres­i­dent of
late stage tech­ni­cal de­vel­op­ment and man­u­fac­tur­ing (be­yond hu­man proof of con­cept) for Mod­er­na.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.